Oscar Health, Inc. Hits New 52-Week High of $29.29

Oscar Health, Inc. has reached a significant milestone by hitting a new 52-week high of USD 29.29 on June 10, 2026. This achievement marks a notable performance for the small-cap company within the healthcare services industry, especially considering its one-year performance of 35.79%, which outpaces the S&P 500's return of 20.34%. Despite facing challenges, including a history of negative operating profits, Oscar Health has shown resilience in its stock performance. The company's market capitalization stands at USD 3,320 million, reflecting its position in the small-cap segment. Key financial metrics indicate a price-to-book ratio of 3.40, while the debt-to-equity ratio is reported at -3.64, suggesting a unique financial structure. The stock's journey from a 52-week low of USD 10.69 to its current high illustrates a significant recovery and growth trajectory. Investors and market observers will be keen to monitor how Oscar Health navigates its operational landscape moving forward, especially in light of its recent performance indicators.